This content is machine translated Gliomas New indications for immuno-oncology? While immunotherapies are rapidly gaining ground in other entities, they are still in their infancy in CNS tumors. This is due in part to the often low immunogenicity. Nevertheless, antibody-based therapies,…
View Post 6 min This content is machine translated Prognosis and biology of gliomas Why low-malignant gliomas are currently not curable Grade II gliomas tend to be underestimated in their malignancy in the early stages. There is no standard for treatment. In addition to wait-and-see, aggressive surgical tactics are becoming more…
